Tourwé D - Search Results

1

Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity.

Egli A, Alberto R, Tannahill L, Schibli R, Abram U, Schaffland A, Waibel R, Tourwé D, Jeannin L, Iterbeke K, Schubiger PA. Egli A, et al. Among authors: tourwe d. J Nucl Med. 1999 Nov;40(11):1913-7. J Nucl Med. 1999. PMID: 10565789 Free article.

2

Catabolism of neurotensins. Implications for the design of radiolabeling strategies of peptides.

Schubiger PA, Allemann-Tannahill L, Egli A, Schibli R, Alberto R, Carrel-Rémy N, Willmann M, Bläuenstein P, Tourwé D. Schubiger PA, et al. Among authors: tourwe d. Q J Nucl Med. 1999 Jun;43(2):155-8. Q J Nucl Med. 1999. PMID: 10429510

3

In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors.

García-Garayoa E, Allemann-Tannahill L, Bläuenstein P, Willmann M, Carrel-Rémy N, Tourwé D, Iterbeke K, Conrath P, Schubiger PA. García-Garayoa E, et al. Among authors: tourwe d. Nucl Med Biol. 2001 Jan;28(1):75-84. doi: 10.1016/s0969-8051(00)00190-6. Nucl Med Biol. 2001. PMID: 11182567

4

Biodistribution and catabolism of (18)F-labeled neurotensin(8-13) analogs.

Bergmann R, Scheunemann M, Heichert C, Mäding P, Wittrisch H, Kretzschmar M, Rodig H, Tourwé D, Iterbeke K, Chavatte K, Zips D, Reubi JC, Johannsen B. Bergmann R, et al. Among authors: tourwe d. Nucl Med Biol. 2002 Jan;29(1):61-72. doi: 10.1016/s0969-8051(01)00284-0. Nucl Med Biol. 2002. PMID: 11786277

5

Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc.

García-Garayoa E, Bläuenstein P, Bruehlmeier M, Blanc A, Iterbeke K, Conrath P, Tourwé D, Schubiger PA. García-Garayoa E, et al. Among authors: tourwe d. J Nucl Med. 2002 Mar;43(3):374-83. J Nucl Med. 2002. PMID: 11884498 Free article.

6

Stabilization of neurotensin analogues: effect on peptide catabolism, biodistribution and tumor binding.

Bruehlmeier M, Garayoa EG, Blanc A, Holzer B, Gergely S, Tourwé D, Schubiger PA, Bläuenstein P. Bruehlmeier M, et al. Among authors: tourwe d. Nucl Med Biol. 2002 Apr;29(3):321-7. doi: 10.1016/s0969-8051(01)00304-3. Nucl Med Biol. 2002. PMID: 11929702

7

A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent.

La Bella R, Garcia-Garayoa E, Bahler M, Bläuenstein P, Schibli R, Conrath P, Tourwé D, Schubiger PA. La Bella R, et al. Among authors: tourwe d. Bioconjug Chem. 2002 May-Jun;13(3):599-604. doi: 10.1021/bc015571a. Bioconjug Chem. 2002. PMID: 12009951

8

Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients.

Buchegger F, Bonvin F, Kosinski M, Schaffland AO, Prior J, Reubi JC, Bläuenstein P, Tourwé D, García Garayoa E, Bischof Delaloye A. Buchegger F, et al. Among authors: tourwe d. J Nucl Med. 2003 Oct;44(10):1649-54. J Nucl Med. 2003. PMID: 14530481 Free article. Clinical Trial.

9

Improving the tumor uptake of 99mTc-labeled neuropeptides using stabilized peptide analogues.

Bläuenstein P, Garayoa EG, Rüegg D, Blanc A, Tourwé D, Beck-Sickinger A, Schubiger PA. Bläuenstein P, et al. Among authors: tourwe d. Cancer Biother Radiopharm. 2004 Apr;19(2):181-8. doi: 10.1089/108497804323071959. Cancer Biother Radiopharm. 2004. PMID: 15186598

10

Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.

García-Garayoa E, Maes V, Bläuenstein P, Blanc A, Hohn A, Tourwé D, Schubiger PA. García-Garayoa E, et al. Among authors: tourwe d. Nucl Med Biol. 2006 May;33(4):495-503. doi: 10.1016/j.nucmedbio.2006.01.007. Epub 2006 May 2. Nucl Med Biol. 2006. PMID: 16720241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters